Risperidone 1 MG/ML Oral Solution — RxCUI 199387
RxNorm drug concept · Semantic clinical drug
RxCUI 199387
Semantic clinical drug · SCD
● Current RxNorm concept 21 FDA products
22 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI199387
Official nameRisperidone 1 MG/ML Oral Solution
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asrisperidone 1 MG per 1 ML Oral Solution; risperiDONE 1 MG in 1 mL Oral Solution
FDA products mapped21
Package NDCs mapped22
Reported Medicaid activity (SDUD)167,950 prescriptions · 52 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Risperidone Injection: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- That's a really common question. The injection is a long-acting, extended-release form of risperidone — it slowly releases medication from the injection site over time, so you don'...
- Why do I need an injection instead of just taking a pill every day?
- Great question — this trips a lot of people up. The injection takes a little time to fully kick in because it releases medication slowly from a depot under the skin. To make sure y...
- Why do I have to take pills for the first few weeks after starting the injection?
🕸️ Concept Web — How Risperidone 1 MG/ML Oral Solution Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Risperidone 1 MG/ML Oral Solution
RxCUI 199387 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Risperidone
35636IN
-
Risperidone
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Risperdal
152318BN
-
Risperdal
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Risperidone Oral Solution
373790SCDF -
Risperidone Oral Liquid Product
1165479SCDG -
Risperidone Oral Product
1165480SCDG -
Risperidone Oral Solution [Risperdal]
364685SBDF -
Risperdal Oral Liquid Product
1185340SBDG -
Risperdal Oral Product
1185341SBDG -
Oral Solution
316968DF -
Oral Liquid Product
1151137DFG - +1 more in this family
-
Risperidone Oral Solution
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Risperidone 1 MG/ML
316644SCDC -
Risperidone 1 MG/ML Oral Solution [Risperdal]
211489SBD -
Risperidone 1 MG/ML [Risperdal]
571874SBDC
-
Risperidone 1 MG/ML
Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Risperidone 1 MG/ML
SCDC · 316644 -
Risperidone Oral Solution
SCDF · 373790 -
Risperidone Oral Liquid Product
SCDG · 1165479 -
Risperidone Oral Product
SCDG · 1165480
Brand-Name Concepts
-
Risperidone 1 MG/ML Oral Solution [Risperdal]
SBD · 211489 -
Risperidone 1 MG/ML [Risperdal]
SBDC · 571874 -
Risperidone Oral Solution [Risperdal]
SBDF · 364685 -
Risperdal Oral Liquid Product
SBDG · 1185340 -
Risperdal Oral Product
SBDG · 1185341 -
Risperdal
BN · 152318
📦 FDA Products & Package NDCs
21 products · 22 package NDCs
22 package NDCs map to RxCUI 199387 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 27808-0002-01 | 30 mL in 1 BOTTLE, UNIT-DOSE (27808-002-01) | Risperidone | Cranbury Pharmaceuticals, LLC | 2015-03-13 |
| 50458-0300-01 | 10 BLISTER PACK in 1 BOX, UNIT-DOSE (50458-300-01) / 10 TAB... | RISPERDAL | Janssen Pharmaceuticals, Inc. | 1993-12-29 |
| 50458-0300-06 | 60 TABLET in 1 BOTTLE (50458-300-06) | RISPERDAL | Janssen Pharmaceuticals, Inc. | 1993-12-29 |
| 50458-0302-01 | 10 BLISTER PACK in 1 BOX, UNIT-DOSE (50458-302-01) / 10 TAB... | RISPERDAL | Janssen Pharmaceuticals, Inc. | 1993-12-29 |
| 50458-0302-06 | 60 TABLET in 1 BOTTLE (50458-302-06) | RISPERDAL | Janssen Pharmaceuticals, Inc. | 1993-12-29 |
| 50458-0305-03 | 30 mL in 1 BOTTLE (50458-305-03) | RISPERDAL | Janssen Pharmaceuticals, Inc. | 1996-06-10 |
| 50458-0320-01 | 10 BLISTER PACK in 1 BOX, UNIT-DOSE (50458-320-01) / 10 TAB... | RISPERDAL | Janssen Pharmaceuticals, Inc. | 1993-12-29 |
| 50458-0320-06 | 60 TABLET in 1 BOTTLE (50458-320-06) | RISPERDAL | Janssen Pharmaceuticals, Inc. | 1993-12-29 |
| 50458-0330-06 | 60 TABLET in 1 BOTTLE (50458-330-06) | RISPERDAL | Janssen Pharmaceuticals, Inc. | 1993-12-29 |
| 50458-0350-01 | 10 BLISTER PACK in 1 BOX, UNIT-DOSE (50458-350-01) / 10 TAB... | RISPERDAL | Janssen Pharmaceuticals, Inc. | 1993-12-29 |
| 50458-0350-06 | 60 TABLET in 1 BOTTLE (50458-350-06) | RISPERDAL | Janssen Pharmaceuticals, Inc. | 1993-12-29 |
| 50458-0596-01 | 30 mL in 1 BOTTLE (50458-596-01) | Risperidone | Janssen Pharmaceutical, Inc. | 1996-06-10 |
| 62135-0929-43 | 30 mL in 1 BOTTLE (62135-929-43) | RISPERIDONE | Chartwell RX, LLC | 2022-07-28 |
| 62559-0981-30 | 30 mL in 1 BOTTLE (62559-981-30) | Risperidone | ANI Pharmaceuticals, Inc. | 2025-10-27 |
| 65162-0673-84 | 30 mL in 1 BOTTLE (65162-673-84) | Risperidone | Amneal Pharmaceuticals LLC | 2011-05-31 |
| 65862-0167-01 | 1 BOTTLE in 1 CARTON (65862-167-01) / 30 mL in 1 BOTTLE | RISPERIDONE | Aurobindo Pharma Limited | 2019-03-25 |
| 65862-0167-30 | 1 BOTTLE, GLASS in 1 CARTON (65862-167-30) / 30 mL in 1 BOT... | RISPERIDONE | Aurobindo Pharma Limited | 2019-03-25 |
| 70518-3741-00 | 10 CUP, UNIT-DOSE in 1 BOX (70518-3741-0) / 2 mL in 1 CUP,... | Risperidone | REMEDYREPACK INC. | 2023-06-01 |
| 70518-3760-00 | 10 CUP, UNIT-DOSE in 1 BOX (70518-3760-0) / 2 mL in 1 CUP,... | Risperidone | REMEDYREPACK INC. | 2023-06-12 |
| 71335-2733-01 | 30 mL in 1 BOTTLE (71335-2733-1) | Risperidone | Bryant Ranch Prepack | 2025-07-29 |
| 72162-2037-02 | 30 mL in 1 BOTTLE (72162-2037-2) | Risperidone | Bryant Ranch Prepack | 2023-06-06 |
| 72162-2037-03 | 30 mL in 1 BOTTLE (72162-2037-3) | Risperidone | Bryant Ranch Prepack | 2023-06-06 |
Observed labelers:
Janssen Pharmaceuticals, Inc. (10) ·
Bryant Ranch Prepack (3) ·
Aurobindo Pharma Limited (2) ·
REMEDYREPACK INC. (2) ·
Amneal Pharmaceuticals LLC (1) ·
ANI Pharmaceuticals, Inc. (1)
· +3 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.